Skip to main content
OpenTrials

Clinical trial condition

Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL)

Explore clinical trials studying Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) trial results

Completed

Copanlisib With Ibrutinib for Patients With Recurrent/ Refractory Primary Central Nervous System Lymphoma (PCNSL)

NCT03581942

Conditions
Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL)
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details